Identification of Sequences in Epstein-Barr Virus DNA Required for the Expression of the Second Epstein-Barr Virus-determined Nuclear Antigen in COS-1 Cells
The BamHI W YH region of the Epstein-Barr virus (EB V) genome encodes a protein localized to the nucleus of the infected cell, the EBV-determined nuclear antigen EBNA2. We have constructed a series of recombinant vectors that carried the complete EBNA2 gene, or the gene modified so as to contain defined deletions involving presumed exons and regulatory elements of the gene. The recombinant vectors were transfected into COS-1 cells which permit the replication of simian virus 40 origin-containing plasmids to a high copy number, and the transient expression of EBNA2 was analysed. A recombinant plasmid that carried a BglII-NotI subfragment of the BamHI WYH region (nucleotides 44664 to 50628) contained all the information necessary for inducing the expression of a full length EBNA2 polypeptide. Moreover, EBV DNA sequences between nucleotides 45442 and 48337 could be deleted without interfering with the ability of the vectors to induce EBNA2. On the other hand the loss of the left one-third of the BglII-NotI fragment completely abolished the EBNA2- inducing capacity of the vector. A rightward promoter consensus sequence in the BamHI W part of the BglII-NotI fragment was functional in COS-1 cells expressing EBNA2 and essential for EBV-specific RNA synthesis. The results indicated that transcription of the EBNA2 gene was initiated in the BamHI W fragment, that the transcript was spliced and that all of EBNA2 was encoded within the continuous long open reading frame in the BamHI Y and H fragments.
ArrandJ. R.,
RymoL.,
WalshJ. E.,
BjorkE.,
LindahlT.,
GriffinB.1981; Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Research 9:2999–3014
BodescotM.,
ChambraudB.,
FarrellP.,
PerricaudetM.1984; Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide. EMBO Journal 3:1913–1917
BurnetteW. N.1981; “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfatepolyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated Protein A. Analytical Biochemistry 112:195–203
ChirgwinJ. M.,
PrzybylaA. E.,
MacDonaldR. J.,
RutterW. J.1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
DambaughT.,
WangF.,
HennessyK.,
WoodlandE.,
RickinsonA.,
KieffE.1986; Expression of the Epstein- Barr virus nuclear protein 2 in rodent cells. Journal of Virology 59:453–462
DillnerJ.,
SternåsL.,
KallinB.,
AlexanderH.,
Ehlin-HenrikssonB.,
JörnvallH.,
KleinG.,
LernerR.1984; Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proceedings of the National Academy of Sciences U.S.A.: 814652–4656
DillnerJ.,
KallinB.,
AlexanderH.,
ErnbergI.,
UnoM.,
KleinG.1986; An Epstein-Barr virus (EBV) determined nuclear antigen (EBNA-5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Proceedings of the National Academy of Sciences U.S.A.: 836641–6645
FisherD. K.,
RobertM. F.,
SheddD.,
SummersW. P.,
RobinsonJ. E.,
WolakJ.,
StefanoE. J.,
MillerG.1984; Identification of an Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2-9-kilobase pair subfragment of the genome. Proceedings of the National Academy of Sciences U.S.A.: 8143–47
HennessyK.,
KieffE.1983; One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proceedings of the National Academy of Sciences U.S.A.: 805665–5669
HennessyK.,
FennewaldS.,
KieffE.1985; A third nuclear protein in lymphoblasts immortalized by Epstein- Barr virus. Proceedings of the National Academy of Sciences U.S.A.: 825944–5948
HennessyK.,
WangF.,
Woodland BushmanE.,
KieffE.1986; Definitive identification of A member of the Epstein-Barr virus nuclear protein 3 family. Proceedings of the National Academy of Sciences U.S.A.: 835693–5697
JonesM. D.,
FosterL.,
SheedyT.,
GriffinB. E.1984; The EB virus genome in Daudi Burkitt’s lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO Journal 3:813–821
KallinB.,
DillnerJ.,
ErnbergI.,
Ehlin-HenrikssonB.,
RosenA.,
HenleW.,
HenleG.,
KleinG.1986; Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proceedings of the National Academy of Sciences U.S.A.: 831499–1503
McCutchanJ. H.,
PaganoJ. S.1968; Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethyl-aminoethyl-dextran. Journal of National Cancer Institute 41:351–357
MellonP.,
ParkerV.,
GluzmanY.,
ManiatisT.1981; Identification of DNA sequences required for transcription of the human al-globin gene in a new SV40 host-vector system. Cell 27:279–288
Mueller-LantzschN,
SauterM.,
TakakiK.,
BechetJ.-M.,
Kuklik-RoosC.,
WunderlichD.1985; Identification of the coding region for a second Epstein-Barr virus nuclear antigen (EBNA2) by transfection of cloned DNA fragments. EMBO Journal 4:1805–1811
ReedmanB. M.,
KleinG.1973; Cellular localization of an Epstein-Barr virus (EBV) associated complementfixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:599–620
RoweD.,
HestonL.,
MetlayJ.,
MillerG.1985; Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1. Proceedings of the National Academy of Sciences U.S.A.: 827429–7433
RymoL.,
KleinG.,
RickstenA.1985; Expression of a second Epstein-Barr virus determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome. Proceedings of the National Academy of Sciences U.S.A.: 823435–3439
SampleJ.,
HummelM.,
BraunD.,
BirkenbachM.,
KieffE.1986; Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proceedings of the National Academy of Sciences U.S.A.: 835096–5100
SculleyT. B.,
WalkerP. J.,
MossD. J.,
PopeJ. H.1984; Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. Journal of Virology 52:88–93
SpeckS. H.,
StromingerJ. L.1985; Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons. Proceedings of the National Academy of Sciences U.S.A.: 828305–8309
StrnadB. C.,
SchusterT. C.,
HopkinsR. F.IIINeubauerR. H.,
RabinH.1981; Identification of an Epstein- Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis. Journal of Virology 38:996–1004
SummersW. P.,
GroganE. A.,
SheddD.,
RobertM.,
LiuC.,
MillerG.1982; Stable expression in mouse cells of nuclear neoantigen after transfer of a 3-4-megadalton cloned fragment of Epstein-Barr virus DNA. Proceedings of the National Academy of Sciences U.S.A.: 795688–5692
Van SantenV.,
CheungA.,
HummelM.,
KieffE.1983; RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells. Journal of Virology 46:424–433
WeaverR. F.,
WeissmannC.1979; Mapping of RNA by a modification of the Berk-Sharp procedure: the 5ʹ termini of the 15 S β-globin mRNA precursor and mature 10 S β-globin mRNA have identical map coordinates. Nucleic Acids Research 7:1175–1193
Identification of Sequences in Epstein-Barr Virus DNA Required for the Expression of the Second Epstein-Barr Virus-determined Nuclear Antigen in COS-1 Cells